Lazyguns ,you are spot on.capper is back .IMO based on earnings,NTA,& refinancing issues been resolved this stock is under valued.DYOR
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%